Accelrys Releases the SciTegic Enterprise Server(TM) 7.0 Platform for Scientific Research Informatics

New Platform Enables Enterprise Collaboration and Advanced Decision Making

SAN DIEGO–Accelrys, Inc. (NASDAQ:ACCL – News), the leading provider of scientific business intelligence software and services, today announced the release of SciTegic Enterprise Server™ 7.0, the premier platform for the integration, analysis, and reporting of scientific data. This new release enhances the enterprise scalability, security, and deployment capabilities required by informatics professionals in the pharmaceutical, biotechnology, and chemicals industries.

“The release of SciTegic Enterprise Server 7.0 represents a major milestone for Accelrys and our customers. This release extends the enterprise capabilities of our platform which will improve productivity and help our customers make more informed, real time decisions,” said Mark J. Emkjer, president and chief executive officer of Accelrys. “This is great news for our customers, including 19 of the top 20 pharmaceutical companies who use our platform for their scientific research informatics.”

Key features of the new release, which is the next generation of the highly successful Pipeline Pilot platform, include a service oriented architecture environment, enterprise collaborative tools, interactive application building, and workflow parallelization.

Accelrys will be demonstrating SciTegic Enterprise Server 7.0 at the BioIT World Conference April 28-30, 2008 in Boston in Booth 201 and showing integration of the platform with technologies from Agilent, HP, and Microsoft.

For more information about SciTegic Enterprise Server 7.0, please visit

About Accelrys, Inc.

Accelrys develops and commercializes scientific business intelligence software for the integration, mining, analysis, modeling and simulation, management and interactive reporting of scientific data. Our solutions are used by biologists, chemists, materials scientists, and information technology professionals for product design as well as drug discovery and development. Our technology and services are designed to meet the needs of today’s leading research and development organizations including leading commercial, government and academic organizations. Many of the largest pharmaceutical, biotechnology, chemical, and petroleum companies worldwide use our solutions. Accelrys is headquartered in San Diego, California. For more information about Accelrys, visit its website at

Forward-Looking Statements

This press release contains forward-looking statements. Such statements, including statements relating to SciTegic Enterprise Server, including features and potential demand therefore, are subject to risks and uncertainties including, but not limited to, the risks that SciTegic Enterprise Server will not successfully include all features described herein, or achieve market acceptance, demand relating to SciTegic Enterprise Server, and other risks and uncertainties described in documents Accelrys has filed with the Securities and Exchange Commission, including its most recent report on Form 10-K and any subsequent interim filings. All forward-looking statements in this document are qualified entirely by the cautionary statements included in this document and such filings. These risks and uncertainties could cause actual results to differ materially from results expressed or implied by forward-looking statements contained in this document. These forward-looking statements speak only as of the date of this document. Accelrys disclaims any intent or obligation to publicly update or revise any forward-looking statements contained herein to reflect any change in its expectations with regard thereto or any change in events, conditions or circumstances on which any such statement is based.

< | >